- Home
- RXT vs OCGN Comparison
RXT vs OCGN Comparison
Compare RXT & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- OCGN
- Stock Information
- Founded
- RXT 1998
- OCGN 2013
- Country
- RXT United States
- OCGN United States
- Employees
- RXT N/A
- OCGN N/A
- Industry
- RXT EDP Services
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RXT Technology
- OCGN Health Care
- Exchange
- RXT Nasdaq
- OCGN Nasdaq
- Market Cap
- RXT 322.8M
- OCGN 278.3M
- IPO Year
- RXT 2020
- OCGN N/A
- Fundamental
- Price
- RXT $1.27
- OCGN $1.03
- Analyst Decision
- RXT Hold
- OCGN Strong Buy
- Analyst Count
- RXT 4
- OCGN 3
- Target Price
- RXT $1.63
- OCGN $6.00
- AVG Volume (30 Days)
- RXT 1.2M
- OCGN 5.9M
- Earning Date
- RXT 08-07-2025
- OCGN 08-07-2025
- Dividend Yield
- RXT N/A
- OCGN N/A
- EPS Growth
- RXT N/A
- OCGN N/A
- EPS
- RXT N/A
- OCGN N/A
- Revenue
- RXT $2,711,700,000.00
- OCGN $4,522,000.00
- Revenue This Year
- RXT N/A
- OCGN N/A
- Revenue Next Year
- RXT $1.48
- OCGN N/A
- P/E Ratio
- RXT N/A
- OCGN N/A
- Revenue Growth
- RXT N/A
- OCGN N/A
- 52 Week Low
- RXT $1.00
- OCGN $0.52
- 52 Week High
- RXT $3.41
- OCGN $1.98
- Technical
- Relative Strength Index (RSI)
- RXT 50.93
- OCGN 55.00
- Support Level
- RXT $1.16
- OCGN $0.95
- Resistance Level
- RXT $1.30
- OCGN $1.15
- Average True Range (ATR)
- RXT 0.10
- OCGN 0.11
- MACD
- RXT 0.01
- OCGN -0.02
- Stochastic Oscillator
- RXT 37.90
- OCGN 22.62
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").